Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes: A Randomized, Open-Label, Two-Period Crossover Outpatient Study
Latest Information Update: 13 Apr 2023
At a glance
- Drugs Dasiglucagon (Primary) ; Carbohydrates; Insulin
- Indications Hypoglycaemia; Type 1 diabetes mellitus
- Focus Therapeutic Use
- 11 Apr 2023 Results assessing the efficacy, safety and feasibility of pen-administered low-dose dasiglucagon for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions published in the Diabetologia
- 07 Jun 2022 Primary endpoint has not been met. (Difference in percentage of time in range between the two study periods), as per Results presented at the 82nd Annual Scientific Sessions of the American Diabetes Association
- 07 Jun 2022 Results presented at the 82nd Annual Scientific Sessions of the American Diabetes Association